Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Joachim E. Roehr"'
Autor:
Kent W. Neuenschwander, Anthony C. Scotese, Larry Davis, Joachim E. Roehr, Shannon Dwyer, Neil Moorcroft, Zhongli Gao, Andrew Giovanni
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 23:1498-1501
A series of tetrahydroisoquinolines were designed, synthesized and evaluated as the first non-natural product type of compounds with dual D1 receptor (D1R) agonism and D2 receptor (D2R) antagonism properties for treatment of schizophrenia. The initia
Autor:
Gregory M. Shutske, Joachim E. Roehr
Publikováno v:
Journal of Heterocyclic Chemistry. 34:789-795
A number of 3-substituted 6-piperazinylpyrazolo[3,4-b]pyridines were synthesized from 2,6-difluoropyridine by directed ortho metallation and sequential intra- and intermolecular displacement of fluorine. Three derivatives with a cyano group in the 3-
Autor:
Jidong Cai, Sathapana Kongsamut, Lei Tang, Lisa L. Kerman, Joachim E. Roehr, Anthony Sandrasagra, Paul Weissensee, Harold B. Hartman
Publikováno v:
European Journal of Pharmacology. 317:417-423
Iloperidone (HP 873; 1-[4-[3-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]propoxy]-3-methoxyphenyl]ethanone) is a compound currently in clinical trials for the treatment of schizophrenia. Iloperidone displays affinity for dopamine D 2 receptors
Autor:
Roy Corbett, Wayne W. Petko, Gina M. Bores, Ann T. Woods-Kettelberger, Sathapana Kongsamut, Craig P. Smith, Joachim E. Roehr, Susan M. Chesson
Publikováno v:
Neurochemical Research. 21:575-583
Examination of HP 184, [N-n-propyl)-N-(3-fluoro-4-pyridinyl) -1H-3-methylindodel-1-amine hydrochloride], in a variety of tests for serotonergic activity revealed some unique properties of this compound. We report here that 100 microM HP 184 enhanced
Autor:
Sam Kongsamut, Deborah E. Bregna, Lisa L. Kerman, Joachim E. Roehr, ‡ and Ann T. Woods-Kettelberger, Mark R. Szewczak, Harold B. Hartman, Jurcak John G, Roy Corbett, Hrib Nicholas J, Kendra L. Burgher, Sharon H. Kafka
Publikováno v:
Journal of Medicinal Chemistry. 39:4044-4057
HP-236 (3-[4-[4-(6-Fluorobenzo[b]thien-3-yl)-1-piperazinyl]butyl]-2,5,5- trimethyl-4-thiazolidinone maleate; P-9236) (54) displayed a pharmacological profile indicative of potential atypical antipsychotic activity. A series of piperazinyl butyl thiaz
Publikováno v:
European Journal of Pharmacology. 278:75-78
Schedule-induced polydipsia was induced when food-deprived rats were subjected to a fixed-time (60 s) feeding schedule for 150 min daily for 3 weeks (training period). Subsequent chronic administration of the serotonin reuptake inhibitor fluoxetine r
Autor:
Paul G. Conway, Joachim E. Roehr, Kendra L. Burgher, Jurcak John G, L. L. Kerman, Harold B. Hartman, Hrib Nicholas J, Woods Ann Theresa
Publikováno v:
Journal of Medicinal Chemistry. 37:2308-2314
A series of benzisoxaazole- and benzisothiazole-3-carboxamides has been prepared and tested for potential antipsychotic activity. In general, the compounds showed an affinity for dopamine D 2 and serotonin 5HT 2A and 5HT 1A receptors. Several members
Autor:
Richard C. Effland, Craig P. Smith, Joseph Thomas Klein, Joachim E. Roehr, Sathapana Kongsamut, Wayne W. Petko, Francis P. Huger
Publikováno v:
Drug Development Research. 32:13-18
N-(n-propyl)-N-(4-pyridinyl)-1H-indol-1-amine (HP 749) is currently in clinical trials for the treatment of Alzheimer's disease (AD). While HP 749 has many pharmacological properties, the biochemical basis for its efficacy in animal models for AD rem
Autor:
Paul G. Conway, Joachim E. Roehr, Hrib Nicholas J, L. L. Kerman, Kendra L. Burgher, Jurcak John G, Woods Ann Theresa, Harold B. Hartman
Publikováno v:
ChemInform. 25
A series of benzisoxaazole- and benzisothiazole-3-carboxamides has been prepared and tested for potential antipsychotic activity. In general, the compounds showed an affinity for dopamine D 2 and serotonin 5HT 2A and 5HT 1A receptors. Several members
Autor:
Mark R. Szewczak, H. B. Hartmann, S. Kongsamut, L. L. Kerman, A. T. Woods-Kettelberger, R. Corbett, Kendra L. Burgher, Jurcak John G, Hrib Nicholas J, D. E. Bregna, Joachim E. Roehr, S. Kafka
Publikováno v:
ChemInform. 28